DHC welcomes Natalie Ward as a Principal Consultant
Natalie brings over 20 years of cell and gene therapy experience, focusing on regulatory CMC strategy for global Phase 2 through 3 studies.
See the latest news and media coverage for DHC. We track all announcements, press releases, and industry mentions in real time, all in one place.
Biotherapeutics development and commercialization consulting firm
darkhorseconsultinggroup.comLast updated
In short: DHC expanded in China, added local development partnerships and broadened its capabilities through acquisitions.
Natalie brings over 20 years of cell and gene therapy experience, focusing on regulatory CMC strategy for global Phase 2 through 3 studies.
Leadership highlights local infrastructure and regulatory pathways to accelerate global biotech programs through dedicated strategic support.
The new office will guide developers through IITs, leveraging China's CDMO and CRO infrastructure.
The growth investment supports expansion in cell and gene therapy consulting. WestView partners join the board.
Dark Horse Consulting Group (DHCG) marked the opening of its Shanghai office with a ribbon cutting ceremony celebrating Dark Horse Consulting China. The event brought...
Dark Horse Consulting Group (DHCG), a leading life sciences consulting firm specializing in advanced therapies, today announced the formation...
Dark Horse Consulting Group (“DHCG” or “the Group”), a leader in strategic and operational biotherapeutics consulting, and Altruist ...
WALNUT CREEK, Calif. and NEW YORK, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Dark Horse Consulting Group ("DHCG" or "the Group"), a leader in strategic and...
Track DHC and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.